Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.
- Resource Type
- Article
- Source
- Drug Design, Development & Therapy; Aug2020, Vol. 14, p3435-3447, 13p
- Subject
- Language
- ISSN
- 11778881